1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20)" is currently closed and not accepting applications.
Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20) is sponsored by National Institutes of Health (NIH). This program provides funding for the alteration, renovation, remodeling, improvement, expansion, or repair of, or completion of shell space in an existing building necessary to make it suitable for use for biomedical research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20) To provide funds for major repair, renovation, and modernization of existing research facilities.
These facilities may be the clinical research facilities, animal research facilities, and other related research facilities. U.S. domestic institutions Only public or private non-profit entities located in the United States or in U.S. territories or possessions are eligible. Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements.
Construction and Modernization OR - Other Research Related, OT - Other Grants for Repair, Renovation and Modernization of Existing Research Facilities Use the Explore NIH Grant Opportunities tool to search Grants. gov. Ready to develop your application? Learn from a step-by-step guide.
Standard Due Dates apply. AIDS and AIDS-Related Applications Beginning with applications for Advisory Council Review in January 2027 (i.e., application due dates on or after May 25, 2026), NIH will no longer accept applications submitted on dedicated AIDS application due dates. ( NOT-OD-26-029 ) Standard Application Due Dates (when applicable) For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Universities and other eligible institutions conducting biomedical research. Confirm the full requirements in the official notice before applying.
The published deadline was September 13, 2024, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Grants for Repair, Renovation and Modernization of Existing Research Facilities (G20) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article